wellrank.ai

Is compounded tirzepatide still available anywhere legitimate?

ClaudequalifiedCollected Jun 26, 2026, 13:30 UTC

Verbatim response from Claude

Compounded Tirzepatide Availability

This is a nuanced situation that's been changing rapidly. Here's the honest picture:

The Short Answer: It's very limited now

The FDA removed tirzepatide (Zepbound/Mounjaro) from its shortage list in late 2024, which effectively ended legal compounding for most pharmacies in early 2025.


What's Still Potentially Legitimate:

  • 503A compounding pharmacies can still compound for specific patients with a documented clinical need/allergy (very limited cases)
  • 503B outsourcing facilities faced a hard stop deadline

Reputable Telehealth Platforms to Ask Directly:

  • Hims & Hers – was offering compounded versions; check current status
  • LifeMD / Rocky – similar situation
  • Sesame Care – connects to licensed providers
  • Your local compounding pharmacy – call and ask directly

Important Cautions:

  • ⚠️ Many websites still selling "compounded tirzepatide" may be operating illegally
  • Watch for salt forms (tirzepatide acetate/HCl) being marketed as legitimate — the FDA has flagged these
  • Stick to platforms requiring actual prescriptions and provider consultations

Best advice: Consult a licensed obesity medicine physician who can navigate current options, including brand-name Zepbound savings programs (Eli Lilly offers significant discounts).

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.